A.L. Jackman

959 total citations
24 papers, 842 citations indexed

About

A.L. Jackman is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, A.L. Jackman has authored 24 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in A.L. Jackman's work include Colorectal Cancer Treatments and Studies (14 papers), Biochemical and Molecular Research (11 papers) and Quinazolinone synthesis and applications (6 papers). A.L. Jackman is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Biochemical and Molecular Research (11 papers) and Quinazolinone synthesis and applications (6 papers). A.L. Jackman collaborates with scholars based in United Kingdom, United States and Israel. A.L. Jackman's co-authors include A H Calvert, Rosemary Kimbell, Melody Brown, William Gibson, G. Wynne Aherne, Anthea Hardcastle, Lloyd R. Kèlland, Jenny Titley, Lisa Brunton and S. J. Harland and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

A.L. Jackman

23 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.L. Jackman United Kingdom	13	513	503	150	140	100	24	842
Lynn S. Gossett United States	10	381 0.7×	475 0.9×	338 2.3×	142 1.0×	148 1.5×	13	943
Rosemary Kimbell United Kingdom	20	576 1.1×	702 1.4×	166 1.1×	162 1.2×	322 3.2×	38	1.2k
Melody Brown United Kingdom	7	292 0.6×	315 0.6×	87 0.6×	82 0.6×	93 0.9×	8	539
Susan B. Gates United States	9	387 0.8×	348 0.7×	347 2.3×	102 0.7×	100 1.0×	11	837
Jesse R. Bewley United States	7	337 0.7×	294 0.6×	328 2.2×	90 0.6×	93 0.9×	9	734
Lillian L. Habeck United States	10	461 0.9×	421 0.8×	467 3.1×	131 0.9×	36 0.4×	16	983
A L Jackman United Kingdom	9	230 0.4×	302 0.6×	78 0.5×	125 0.9×	71 0.7×	12	515
Katherine A. Shackelford United States	8	363 0.7×	303 0.6×	353 2.4×	104 0.7×	31 0.3×	10	741
Daphne Voorn Netherlands	16	539 1.1×	389 0.8×	213 1.4×	27 0.2×	48 0.5×	21	911
D. M. Moccio United States	16	260 0.5×	393 0.8×	101 0.7×	237 1.7×	49 0.5×	21	920

Countries citing papers authored by A.L. Jackman

Since Specialization

Citations

This map shows the geographic impact of A.L. Jackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Jackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Jackman more than expected).

Fields of papers citing papers by A.L. Jackman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.L. Jackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Jackman. The network helps show where A.L. Jackman may publish in the future.

Co-authorship network of co-authors of A.L. Jackman

This figure shows the co-authorship network connecting the top 25 collaborators of A.L. Jackman. A scholar is included among the top collaborators of A.L. Jackman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.L. Jackman. A.L. Jackman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanchez, Julian, Wen Ren, Carlton E. Ash, et al.. (2024). Discovery of Potent and Selective Pyridone-Based Small Molecule Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains. Journal of Medicinal Chemistry. 67(23). 21070–21105.

Krishnan, Bhavani, M.G. Ormerod, Stuart Kaye, & A.L. Jackman. (2004). 637 Effective combinations of carboplatin with low doses of TRAIL, HGS-ETR1 and HGS-ETR2 in the TRAIL-sensitive HX62 human ovarian tumour cell line. European Journal of Cancer Supplements. 2(8). 192–192. 1 indexed citations

Farrugia, David, G. Wynne Aherne, Lisa Brunton, Stephen Clarke, & A.L. Jackman. (2000). Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies.. PubMed. 6(9). 3646–56. 18 indexed citations

Clarke, Stephen, David Farrugia, G. Wynne Aherne, et al.. (2000). Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity.. PubMed. 6(1). 285–96. 20 indexed citations

Titley, Jenny, et al.. (2000). Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.. PubMed. 6(6). 2538–46. 66 indexed citations

Trigo, José, Philip Beale, F. Mitchell, et al.. (1999). Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks. European Journal of Cancer. 35. S286–S286. 10 indexed citations

Mitchell, F., C. Rees, I. Judson, et al.. (1998). Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331. Annals of Oncology. 1 indexed citations

Aherne, G. Wynne, et al.. (1998). Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models. British Journal of Cancer. 77(2). 221–226. 26 indexed citations

Skelton, Lorraine, M.G. Ormerod, Jenny Titley, & A.L. Jackman. (1998). Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action. Cytometry. 33(1). 56–66. 17 indexed citations

10.

Mitchell, F., et al.. (1998). The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice. British Journal of Cancer. 78(11). 1457–1463. 5 indexed citations

11.

Jackman, A.L., et al.. (1995). Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694. British Journal of Cancer. 71(5). 925–930. 33 indexed citations

12.

Kèlland, Lloyd R., Rosemary Kimbell, Anthea Hardcastle, G. Wynne Aherne, & A.L. Jackman. (1995). Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines. European Journal of Cancer. 31(6). 981–986. 27 indexed citations

13.

Jackman, A.L., Lloyd R. Kèlland, Rosemary Kimbell, et al.. (1995). Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. British Journal of Cancer. 71(5). 914–924. 88 indexed citations

14.

Sanghani, Paresh C., A.L. Jackman, T. J. Thornton, et al.. (1994). A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.. Molecular Pharmacology. 45(2). 341–351. 7 indexed citations

15.

Jackman, A.L., et al.. (1991). ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.. PubMed. 51(20). 5579–86. 322 indexed citations

16.

Imam, A., Philip H. Crossley, A.L. Jackman, & Peter Little. (1987). Analysis of thymidylate synthase gene amplification and of mRNA levels in the cell cycle.. Journal of Biological Chemistry. 262(15). 7368–7373. 26 indexed citations

17.

Calvert, A H, Newell, A.L. Jackman, et al.. (1987). Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717).. PubMed. 213–8. 25 indexed citations

18.

Jones, Terence R., AH Calvert, A.L. Jackman, et al.. (1986). ChemInform Abstract: Quinazoline Antifolates Inhibiting Thymidylate Synthase: Variation of the N10 Substituent.. Chemischer Informationsdienst. 17(6). 3 indexed citations

19.

Jackman, A.L., et al.. (1982). BIOCHEMICAL DISTURBANCES OBSERVED INVITRO AND INVIVO FOLLOWING INHIBITION OF THYMIDYLATE SYNTHETASE BY C-3717. UCL Discovery (University College London). 1 indexed citations

20.

Calvert, A H, et al.. (1979). 2-AMINO-4-HYDROXY QUINAZOLINE ANALOGS OF FOLIC-ACID AS THYMIDYLATE SYNTHETASE INHIBITORS. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact